Author

P. Bullova

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 2 Research Focus:differential expression· 2 Approach:experimental assay· 2 Organism:human· 2 Assay:bulk RNA-seq· 1 Research Focus:cell-cell communication· 1 Research Focus:drug response / drug discovery· 1 Assay:scRNA-seq· 1

Frequent Co-Authors

C. Larsson· 2 shared J. Holmberg· 2 shared P. Kogner· 2 shared S. Schlisio· 2 shared A. Stenman· 1 shared C. C. Juhlin· 1 shared C. Juhlin· 1 shared E. Maxymovitz· 1 shared

Activity by Year

2020-2021 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 36 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

C. Larsson

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cancer BiologybioRxivMar 26, 2021

Single-nuclei transcriptomes from human adrenal gland reveals distinct cellular identities of low and high-risk neuroblastoma tumors.

O. C. Bedoya-Reina, W. Li, M. Arceo…·S. Schlisio

The paper identifies distinct cellular identities in low and high-risk neuroblastoma tumors using single-nuclei transcriptomes, linking them to clinical outcomes and age at diagnosis.

DOI 10.1038/s41467-021-24870-7

humanscRNA-seq

𝕏 PostBluesky

Cancer BiologybioRxivPreprintJan 31, 2020

Alternative splicing in neuroblastoma generates RNA-fusion transcripts and is associated with vulnerability to spliceosome inhibitors

Y. Shi, V. Rraklli, E. Maxymovitz…·J. Holmberg

This study identifies splicing-dependent RNA-fusions in neuroblastoma and shows spliceosome inhibition reduces tumor growth.

DOI 10.1101/851238

humanbulk RNA-seq

𝕏 PostBluesky